English
Romanian
We are absolutely thrilled to announce that PROMED – the Innovative Screening Tool for Colorectal and Lung Cancer – has emerged victorious, securing the prestigious ATIC Nomination for the 2023 World Innovation, Technology, and Services Alliance Award!
This exceptional recognition is a testament to the unwavering support and unparalleled dedication of our remarkable team, led by the visionary CEO Eng. Flaviana Rotaru and our stellar team Prof. Dr. Florina Bojin, Eng. Marius P. Ivanov, Prof. Dr. Dragos Cristea, Ec. Ana Duca, along with an array of medical doctors, IT specialists, and consultants have poured their hearts into this groundbreaking project.
PROMED embarked on its transformative journey three years ago, fuelled by the generous financial backing of the Competitiveness Operational Programme 2014-2020, co-financed through the European Regional Development Fund (ERDF), Priority Axis 2 “Information and Communication Technology (ICT) for a competitive digital economy”. This journey was further propelled by the support of The National Credit Guarantee Fund for SMEs, First Bank, and a league of dedicated private investors who believed wholeheartedly in our team and our project.
In a world where over 30 million lives are tragically claimed by cancer every year, early diagnosis stands as an absolute linchpin in elevating survival rates and alleviating the strain on healthcare systems. PROMED represents an awe-inspiring leap towards achieving this noble goal, a beacon of hope that illuminates the path toward a healthier, brighter future.
Here’s to PROMED’s resplendent success, an emblem of innovation and excellence in the realm of eHealth solutions. Let us continue to shine, bringing radiance and positivity to the lives of millions.